Immunology
The Immunology TA strives to develop and deliver differentiated solutions that transform lives and bring hope to people living with chronic inflammatory and immunological diseases. Building off the rich heritage of innovation in monoclonal antibody therapeutics and immunologic diseases and expanding to oral and inhaled medicines for immunologic and pulmonary diseases, the Immunology TA works to develop solutions for chronic inflammatory diseases. Our colleagues are passionate about discovering new solutions to combat complex immunological diseases – rheumatoid arthritis, inflammatory bowel disease, psoriasis and pulmonary diseases, including asthma, COPD and other inflammatory lung diseases with high unmet needs.
PDF Attachments:
